Preprint Communication Version 1 Preserved in Portico This version is not peer-reviewed

From CBT to Complex Therapy: A Novel Approach to the Treatment of Mental Disorders

Version 1 : Received: 10 March 2024 / Approved: 11 March 2024 / Online: 11 March 2024 (10:29:07 CET)

How to cite: Scrimali, T. From CBT to Complex Therapy: A Novel Approach to the Treatment of Mental Disorders. Preprints 2024, 2024030594. https://doi.org/10.20944/preprints202403.0594.v1 Scrimali, T. From CBT to Complex Therapy: A Novel Approach to the Treatment of Mental Disorders. Preprints 2024, 2024030594. https://doi.org/10.20944/preprints202403.0594.v1

Abstract

This communication explores the transition from Cognitive Behavioural Therapy (CBT) to a more holistic model, named Complex Therapy, developed by Tullio Scrimali for explaining and treating mental disorders. The Author delves into the limitations of traditional CBT and introduces an innovative framework that integrates multiple therapeutic modalities. While CBT is based on the study and modification of behaviour and cognition, Complex Therapy includes, in its focus, the theory of human relationships, the attachment theory, neuroscience, applied neuroscience, complex systems theory and ecology.Complex Therapy addresses the multifaceted nature of mental health issues by combining evidence-based techniques with personalized care strategies. The goal is to enhance patient outcomes through a tailored, comprehensive treatment plan that adapts to the evolving needs of individuals facing mental health challenges.Two innovative and original items which Scrimali has developed, which are a device for Applied Neuroscience MindLAB Set and a new botanical drug, NegEnt, are presented and discussed.The topic also describes, an original and integrated protocol, named Negative Entropy, the author has developed for treating a challenging disorder, such as schizophrenia, he renamed Entropy of Mind.

Keywords

Complex Therapy; Psychiatry; Psychotehrapy; CBT; MindLAB Set; NegEnt

Subject

Medicine and Pharmacology, Psychiatry and Mental Health

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.